Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBITDA Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed EBITDA Margin for 6 consecutive years, with 3.05% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 519.0% to 3.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.61% through Dec 2025, up 531.0% year-over-year, with the annual reading at 0.61% for FY2025, 531.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 3.05% at LifeStance Health, up from 0.2% in the prior quarter.
  • The five-year high for EBITDA Margin was 3.05% in Q4 2025, with the low at 69.29% in Q3 2021.
  • Average EBITDA Margin over 5 years is 18.16%, with a median of 15.0% recorded in 2022.
  • The sharpest move saw EBITDA Margin plummeted -6606bps in 2021, then soared 5336bps in 2022.
  • Over 5 years, EBITDA Margin stood at 56.86% in 2021, then skyrocketed by 64bps to 20.3% in 2022, then rose by 17bps to 16.76% in 2023, then skyrocketed by 87bps to 2.14% in 2024, then surged by 243bps to 3.05% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 3.05%, 0.2%, and 1.18% for Q4 2025, Q3 2025, and Q2 2025 respectively.